Report Detail

Request for Sample of this report

Pharma & Healthcare Global POC DIAGNOSTICS Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type

  • RnM4140903
    • |
  • 23 June, 2021
    • |
  • Global
    • |
  • 112 Pages
    • |
  • XYZResearch
    • |
  • Pharma & Healthcare

Global markets continue to sink as the coronavirus spreads, reaching over 200 countries in total by the end of March. Now the outbreak continued to grow, as the number of cases in USA, Italy, Spain, Germany, France all spiked, Europe and USA have now become the epicenter of the outbreak, Cases in China appear have steadied in April, but there’s growing concern about the overall impact to the global market. This study analysis was given on a worldwide scale, for instance, present and traditional POC DIAGNOSTICSgrowth analysis, competitive analysis, and also the growth prospects of the central regions. The report gives an exhaustive investigation of this market at country & regional levels, and provides an analysis of the industry trends in each of the sub-segments, from sales, revenue and consumption. A quantitative and qualitative analysis of the main players in related regions is introduced, from the perspective of sales, revenue and price.
According to XYZResearch, the global POC DIAGNOSTICS market was valued at USD xxx million in 2019, and it is expected to reach a value of USD xxx million by 2026, at a CAGR of xx% over the forecast period 2021-2026. Correspondingly, the forecast analysis of POC DIAGNOSTICS industry comprises of Asia, North America, South America, Middle East and Africa, Europe, with the sales and revenue data in each of the sub-segments.
At the upcoming section, this report discusses industrial policy, economic environment, in addition to the fabrication processes and cost structures of the industry. And this report encompasses the fundamental dynamics of the market which include drivers, opportunities, and challenges faced by the industry. Additionally, this report showed a keen market study of the main consumers, raw material manufacturers and distributors, etc.
In order to stop the spread of the COVID-19 outbreak, countries and world capital have been put under strict lockdown, bringing a total halt to major industrial production chains. It has caused supply chain disruptions for nearly three-quarters of U.S. companies, and in the second quarter, domestically consumption is likely to be hit even harder. The same situation also appeared in Europe, as the epidemic has required large-scale restrictions on the movement of people, investment, consumption and exports will all be strongly impacted by the epidemic, domestic production and consumption will plummet in the first half of 2020. We expected a U-shaped recovery in the second half of the year in USA and Europe market.
China, Japan, South Korea, India, and other Asia countries took the lead in introducing unprecedented measures to contain the virus, the market confidence in Asia-Pacific region is returning, EU and USA have relaxed its fiscal rules with maximum flexibility, this will stimulate the market demand in the second half of 2020.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (M USD), market share and growth rate of POC DIAGNOSTICS in these regions, from 2014 to 2026 (forecast), covering
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
South America (Brazil, Argentina, Columbia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Global POC DIAGNOSTICS market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Alere
Roche
Abbott Laboratories
Johnson & Johnson
Siemens Healthcare
Danaher
Bayer Healthcare
Beckman Coulter
Nipro Diagnostics
Bio-Rad Laboratories
Nova Biomedical
BioMerieux
Quidel
Helena Laboratories
OraSure Technologies
Accriva
Abaxis
Chembio Diagnostics
Trinity Biotech
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Blood Glucose Testing
Infectious Diseases Testing
Cardiac Markers Testing
Coagulation Testing
Pregnancy and Fertility Testing
Blood Gas/Electrolytes Testing
Tumor Markers Testing
Urinalysis Testing
Cholesterol Testing
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of POC DIAGNOSTICS for each application, including
Clinics
Hospitals
Laboratory
Others

If you have any special requirements, please let us know and we will offer you the report as you want.


Table of Contents

    Global POC DIAGNOSTICS Market by Manufacturers, Regions, Type and Application, Forecast to 2026

      1 Report Overview

      • 1.1 Definition and Specification
      • 1.2 Report Overview
        • 1.2.1 Manufacturers Overview
        • 1.2.2 Regions Overview
        • 1.2.3 Type Overview
        • 1.2.4 Application Overview
      • 1.3 Industrial Chain
        • 1.3.1 POC DIAGNOSTICS Overall Industrial Chain
        • 1.3.2 Upstream
        • 1.3.3 Downstream
      • 1.4 Industry Situation
        • 1.4.1 Industrial Policy
        • 1.4.2 Product Preference
        • 1.4.3 Economic/Political Environment
      • 1.5 SWOT Analysis

      2 Market Assessment by Type

      • 2.1 Blood Glucose Testing Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
      • 2.2 Infectious Diseases Testing Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
      • 2.3 Cardiac Markers Testing Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
      • 2.4 Coagulation Testing Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
      • 2.5 Pregnancy and Fertility Testing Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
      • 2.6 Blood Gas/Electrolytes Testing Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
      • 2.7 Tumor Markers Testing Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
      • 2.8 Urinalysis Testing Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
      • 2.9 Cholesterol Testing Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020

      3 Asia Pacific POC DIAGNOSTICS Market Assessment by Type

      • 3.1 Asia Pacific Market Performance (Sales, Revenue)
      • 3.2 Key Players in Asia Pacific

      4 North America POC DIAGNOSTICS Market Assessment by Type

      • 4.1 North America Market Performance (Sales, Revenue)
      • 4.2 Key Players in North America

      5 Europe POC DIAGNOSTICS Market Assessment by Type

      • 4.1 Europe Market Performance (Sales, Revenue)
      • 4.2 Key Players in Europe

      6 South America POC DIAGNOSTICS Market Assessment by Type

      • 4.1 South America Market Performance (Sales, Revenue)
      • 4.2 Key Players in South America

      7 Middle Easr and Africa POC DIAGNOSTICS Market Assessment by Type

      • 4.1 Middle Easr and Africa Market Performance (Sales, Revenue)
      • 4.2 Key Players in Middle Easr and Africa

      8 World POC DIAGNOSTICS Market Assessment by Type

      • 8.1 Asia Pacific POC DIAGNOSTICS Market Assessment by Application (Consumption and Market Share)
      • 8.2 North America POC DIAGNOSTICS Market Assessment by Application (Consumption and Market Share)
      • 8.3 Europe POC DIAGNOSTICS Market Assessment by Application (Consumption and Market Share)
      • 8.4 South America POC DIAGNOSTICS Market Assessment by Application (Consumption and Market Share)
      • 8.5 Middle East and Africa POC DIAGNOSTICS Market Assessment by Application (Consumption and Market Share)

      9 Company Profiles/Analysis

      • 9.1 Alere
        • 9.1.1 Alere Profiles
        • 9.1.2 Alere Product Portfolio
        • 9.1.3 Alere POC DIAGNOSTICS Business Performance
        • 9.1.4 Alere POC DIAGNOSTICS Business Development and Market Status
      • 9.2 Roche
        • 9.2.1 Roche Profiles
        • 9.2.2 Roche Product Portfolio
        • 9.2.3 Roche POC DIAGNOSTICS Business Performance
        • 9.2.4 Roche POC DIAGNOSTICS Business Development and Market Status
      • 9.3 Abbott Laboratories
        • 9.3.1 Abbott Laboratories Profiles
        • 9.3.2 Abbott Laboratories Product Portfolio
        • 9.3.3 Abbott Laboratories POC DIAGNOSTICS Business Performance
        • 9.3.4 Abbott Laboratories POC DIAGNOSTICS Business Development and Market Status
      • 9.4 Johnson & Johnson
        • 9.4.1 Johnson & Johnson Profiles
        • 9.4.2 Johnson & Johnson Product Portfolio
        • 9.4.3 Johnson & Johnson POC DIAGNOSTICS Business Performance
        • 9.4.4 Johnson & Johnson POC DIAGNOSTICS Business Development and Market Status
      • 9.5 Siemens Healthcare
        • 9.5.1 Siemens Healthcare Profiles
        • 9.5.2 Siemens Healthcare Product Portfolio
        • 9.5.3 Siemens Healthcare POC DIAGNOSTICS Business Performance
        • 9.5.4 Siemens Healthcare POC DIAGNOSTICS Business Development and Market Status
      • 9.6 Danaher
        • 9.6.1 Danaher Profiles
        • 9.6.2 Danaher Product Portfolio
        • 9.6.3 Danaher POC DIAGNOSTICS Business Performance
        • 9.6.4 Danaher POC DIAGNOSTICS Business Development and Market Status
      • 9.7 Bayer Healthcare
        • 9.7.1 Bayer Healthcare Profiles
        • 9.7.2 Bayer Healthcare Product Portfolio
        • 9.7.3 Bayer Healthcare POC DIAGNOSTICS Business Performance
        • 9.7.4 Bayer Healthcare POC DIAGNOSTICS Business Development and Market Status
      • 9.8 Beckman Coulter
        • 9.8.1 Beckman Coulter Profiles
        • 9.8.2 Beckman Coulter Product Portfolio
        • 9.8.3 Beckman Coulter POC DIAGNOSTICS Business Performance
        • 9.8.4 Beckman Coulter POC DIAGNOSTICS Business Development and Market Status
      • 9.9 Nipro Diagnostics
        • 9.9.1 Nipro Diagnostics Profiles
        • 9.9.2 Nipro Diagnostics Product Portfolio
        • 9.9.3 Nipro Diagnostics POC DIAGNOSTICS Business Performance
        • 9.9.4 Nipro Diagnostics POC DIAGNOSTICS Business Development and Market Status
      • 9.10 Bio-Rad Laboratories
        • 9.10.1 Bio-Rad Laboratories Profiles
        • 9.10.2 Bio-Rad Laboratories Product Portfolio
        • 9.10.3 Bio-Rad Laboratories POC DIAGNOSTICS Business Performance
        • 9.10.4 Bio-Rad Laboratories POC DIAGNOSTICS Business Development and Market Status
      • 9.11 Nova Biomedical
      • 9.12 BioMerieux
      • 9.13 Quidel
      • 9.14 Helena Laboratories
      • 9.15 OraSure Technologies
      • 9.16 Accriva
      • 9.17 Abaxis
      • 9.18 Chembio Diagnostics
      • 9.19 Trinity Biotech

      10 World POC DIAGNOSTICS Market Assessment by Players

      • 10.1 Global POC DIAGNOSTICS Sales (K Units) and Market Share by Players 2014-2020
      • 10.2 Global POC DIAGNOSTICS Revenue (M USD) and Market Share by Players 2014-2020
      • 10.3 Global POC DIAGNOSTICS Price (USD/Unit) of Players 2014-2020
      • 10.4 Global POC DIAGNOSTICS Gross Margin of Players 2014-2020
      • 10.5 Market Concentration

      11 Regional Market Performance by Segment of Players

      • 11.1 North America
        • 11.1.1 North America POC DIAGNOSTICS Sales Assessment of Players 2014-2020
        • 11.1.2 North America POC DIAGNOSTICS Revenue Assessment of Players 2014-2020
        • 11.1.3 North America POC DIAGNOSTICS Price Assessment of Players 2014-2020
        • 11.1.4 North America POC DIAGNOSTICS Gross Margin Assessment of Players 2014-2020
        • 11.1.5 Market Concentration
      • 11.2 Europe
        • 11.2.1 Europe POC DIAGNOSTICS Sales Assessment of Players 2014-2020
        • 11.2.2 Europe POC DIAGNOSTICS Revenue Assessment of Players of Manufacturers 2014-2020
        • 11.2.3 Europe POC DIAGNOSTICS Price Assessment of Players 2014-2020
        • 11.2.4 Europe POC DIAGNOSTICS Gross Margin Assessment of Players 2014-2020
        • 11.2.5 Market Concentration
      • 11.3 Asia-Pacific Market Performance for Manufacturers
        • 11.3.1 Asia-Pacific POC DIAGNOSTICS Sales Assessment of Players 2014-2020
        • 11.3.2 Asia-Pacific POC DIAGNOSTICS Revenue Assessment of Players 2014-2020
        • 11.3.3 Asia-Pacific POC DIAGNOSTICS Price Assessment of Players 2014-2020
        • 11.3.4 Asia-Pacific POC DIAGNOSTICS Gross Margin Assessment of Players 2014-2020
        • 11.3.5 Market Concentration
      • 11.4 South America Market Performance for Players
        • 11.4.1 South America POC DIAGNOSTICS Sales Assessment of Players 2014-2020
        • 11.4.2 South America POC DIAGNOSTICS Revenue Assessment of Players 2014-2020
        • 11.4.3 South America POC DIAGNOSTICS Price Assessment of Players 2014-2020
        • 11.4.4 South America POC DIAGNOSTICS Gross Margin Assessment of Players 2014-2020
        • 11.4.5 Market Concentration
      • 11.5 Middle East and Africa Market Performance for Players
        • 11.5.1 Middle East and Africa POC DIAGNOSTICS Sales Assessment of Players 2014-2020
        • 11.5.2 Middle East and Africa POC DIAGNOSTICS Revenue Assessment of Players 2014-2020
        • 11.5.3 Middle East and Africa POC DIAGNOSTICS Price Assessment of Players 2014-2020
        • 11.5.4 Middle East and Africa POC DIAGNOSTICS Gross Margin Assessment of Players 2014-2020
        • 11.5.5 Market Concentration

      12 Regional Market Performance by Segment of Countries

      • 12.1 Asia Pacific
        • 12.1.1 Asia Pacific POC DIAGNOSTICS Sales by Countries/Regions 2014-2020
        • 12.1.2 Asia Pacific POC DIAGNOSTICS Revenue by Countries/Regions 2014-2020
        • 12.1.3 Asia Pacific POC DIAGNOSTICS Average Price by Countries/Regions 2014-2020
      • 12.2 North America
        • 12.2.1 North America POC DIAGNOSTICS Sales by Countries/Regions 2014-2020
        • 12.2.2 North America POC DIAGNOSTICS Revenue by Countries/Regions 2014-2020
        • 12.2.3 North America POC DIAGNOSTICS Average Price by Countries/Regions 2014-2020
      • 12.3 Europe
        • 12.3.1 Europe POC DIAGNOSTICS Sales by Countries/Regions 2014-2020
        • 12.3.2 Europe POC DIAGNOSTICS Revenue by Countries/Regions 2014-2020
        • 12.3.3 Europe POC DIAGNOSTICS Average Price by Countries/Regions 2014-2020
      • 12.4 South America
        • 12.4.1 South America POC DIAGNOSTICS Sales by Countries/Regions 2014-2020
        • 12.4.2 South America POC DIAGNOSTICS Revenue by Countries/Regions 2014-2020
        • 12.4.3 South America POC DIAGNOSTICS Average Price by Countries/Regions 2014-2020
      • 12.5 Middle East and Africa
        • 12.5.1 Middle East and Africa POC DIAGNOSTICS Sales by Countries/Regions 2014-2020
        • 12.5.2 Middle East and Africa POC DIAGNOSTICS Revenue by Countries/Regions 2014-2020
        • 12.5.3 Middle East and Africa POC DIAGNOSTICS Average Price by Countries/Regions 2014-2020

      13 Technology and Opportunity

      • 13.1 Technology
      • 13.2 Market Opportunity

      14 World POC DIAGNOSTICS Sales & Revenue Forecast 2021-2026

      • 14.1 World POC DIAGNOSTICS Sales and Revenue Forecast by Regions 2021-2026
        • 14.1.1 World POC DIAGNOSTICSSales and Market Share by Regions
        • 14.1.2 World POC DIAGNOSTICSRevenue and Market Share by Regions

      15 Asia POC DIAGNOSTICS Market Forecast 2021-2026

      • 15.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
        • 15.1.1 Blood Glucose Testing
        • 15.1.2 Infectious Diseases Testing
        • 15.1.3 Cardiac Markers Testing
        • 15.1.4 Coagulation Testing
        • 15.1.5 Pregnancy and Fertility Testing
        • 15.1.6 Blood Gas/Electrolytes Testing
        • 15.1.7 Tumor Markers Testing
        • 15.1.8 Urinalysis Testing
        • 15.1.9 Cholesterol Testing
      • 15.2 Consumption Forecast by Application, 2021-2026

      16 North America POC DIAGNOSTICS Market Forecast 2021-2026

      • 16.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
        • 16.1.1 Blood Glucose Testing
        • 16.1.2 Infectious Diseases Testing
        • 16.1.3 Cardiac Markers Testing
        • 16.1.4 Coagulation Testing
        • 16.1.5 Pregnancy and Fertility Testing
        • 16.1.6 Blood Gas/Electrolytes Testing
        • 16.1.7 Tumor Markers Testing
        • 16.1.8 Urinalysis Testing
        • 16.1.9 Cholesterol Testing
      • 16.2 Consumption Forecast by Application, 2021-2026

      17 Europe POC DIAGNOSTICS Market Forecast 2021-2026

      • 17.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
        • 17.1.1 Blood Glucose Testing
        • 17.1.2 Infectious Diseases Testing
        • 17.1.3 Cardiac Markers Testing
        • 17.1.4 Coagulation Testing
        • 17.1.5 Pregnancy and Fertility Testing
        • 17.1.6 Blood Gas/Electrolytes Testing
        • 17.1.7 Tumor Markers Testing
        • 17.1.8 Urinalysis Testing
        • 17.1.9 Cholesterol Testing
      • 17.2 Consumption Forecast by Application, 2021-2026

      18 South America POC DIAGNOSTICS Market Forecast 2021-2026

      • 18.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
        • 18.1.1 Blood Glucose Testing
        • 18.1.2 Infectious Diseases Testing
        • 18.1.3 Cardiac Markers Testing
        • 18.1.4 Coagulation Testing
        • 18.1.5 Pregnancy and Fertility Testing
        • 18.1.6 Blood Gas/Electrolytes Testing
        • 18.1.7 Tumor Markers Testing
        • 18.1.8 Urinalysis Testing
        • 18.1.9 Cholesterol Testing
      • 18.2 Consumption Forecast by Application, 2021-2026

      19 Middle East and Africa POC DIAGNOSTICS Market Forecast 2021-2026

      • 19.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
        • 19.1.1 Blood Glucose Testing
        • 19.1.2 Infectious Diseases Testing
        • 19.1.3 Cardiac Markers Testing
        • 19.1.4 Coagulation Testing
        • 19.1.5 Pregnancy and Fertility Testing
        • 19.1.6 Blood Gas/Electrolytes Testing
        • 19.1.7 Tumor Markers Testing
        • 19.1.8 Urinalysis Testing
        • 19.1.9 Cholesterol Testing
      • 19.2 Consumption Forecast by Application, 2021-2026

      20 Price (USD/Unit) and Gross Profit Forecast

      • 20.1 Global POC DIAGNOSTICS Price (USD/Unit) Trend 2021-2026
      • 20.2 Global POC DIAGNOSTICS Gross Profit Trend 2021-2026

      21 Conclusion

      Summary:
      Get latest Market Research Reports on POC DIAGNOSTICS. Industry analysis & Market Report on POC DIAGNOSTICS is a syndicated market report, published as Global POC DIAGNOSTICS Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type. It is complete Research Study and Industry Analysis of POC DIAGNOSTICS market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,150.00
      		$6,200.00
      		2,482.20
      		4,885.60
      		2,898.00
      		5,704.00
      		490,140.00
      		964,720.00
      		262,647.00
      		516,956.00
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo